1. BRM/SMARCA2‐negative clear cell renal cell carcinoma is associated with a high percentage of BRM somatic mutations, deletions and promoter methylation. Issue 5 (9th January 2017) Authors: Xia, Qiu‐Yuan; Zhan, Xue‐Mei; Fan, Xiang‐Shan; Ye, Sheng‐Bing; Shi, Shan‐Shan; Li, Rui; Wei, Xue; Wang, Xuan; Ma, Heng‐Hui; Lu, Zhen‐Feng; Zhou, Xiao‐Jun; Rao, Qiu Journal: Histopathology Issue: Volume 70:Issue 5(2017) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗